Eric Snyder, MD, PhD

Associate Professor, University of Utah School of Medicine

Education

• Doctorate Degree—Molecular/Cellular Biology, Washington University
• Medical Degree—Washington University
• Residency—Anatomic Pathology, Brigham and Women’s Hospital
• Postdoctoral Research Fellowship—Massachusetts Institute of Technology

Certifications/Affiliations

• American Board of Pathology (Anatomic Pathology)

Research Interests

• Mouse models of cancer
• Lung cancer
• Pancreatic cancer
• Transcription factors

Awards

• Burroughs Wellcome Career Award for Medical Scientists, 2011
• Pathobiology Prize, United States and Canadian Academy of Pathology, 2009

Recent Publications

• Camolotto, SA, et al. Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4. Gut. 2021;70(5):900–14.
• Kinsey CG, et al. Protective autophagy elicited by RAF→ MEK→ ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat Med. 2019;25(4):620–7.
• Camolotto SA, et al. FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer. Elife. 2018;7:338579.
• Caswell DR, et al. Tumor suppressor activity of Selenbp1, a direct Nkx2-1 target, in lung adenocarcinoma. Mol Cancer Res. 2018;16(11):1737–49.
• Mollaoglu G, et al. The lineage-defining transcription factors SOX2 and NKX2-1 determine lung cancer cell fate and shape the tumor immune microenvironment. Immunity. 2018;49(4):764–79.e9.